Hidradenitis Suppurativa (HS) – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
Hidradenitis suppurativa (HS) is a chronic skin disease that causes painful, boil-like lumps that form under the skin and often secrete pus and blood. Etiology- In most cases, the cause of HS is unknown. In some cases of HS have been associated with specific genes, including NCSTN, PSEN1, and PSENEN. Epidemiology- It is estimated that the prevalence of hidradenitis suppurativa is between 0.5 and 4%, and may affect about 11 in 100,000 people in the US. Females are more likely to be affected than males. The competitive landscape of Hidradenitis Suppurativa (HS) includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary. KOLs insights of Hidradenitis Suppurativa (HS) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteri...